Grape King Bio Ltd (TPE:1707)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
129.50
-4.00 (-3.00%)
Jul 31, 2025, 2:36 PM CST
-3.00%
Market Cap19.78B
Revenue (ttm)11.06B
Net Income (ttm)1.40B
Shares Out148.14M
EPS (ttm)9.38
PE Ratio14.23
Forward PEn/a
Dividend6.90 (5.19%)
Ex-Dividend DateJun 23, 2025
Volume255,263
Average Volume251,708
Open133.00
Previous Close133.50
Day's Range129.50 - 133.00
52-Week Range119.50 - 158.00
Beta0.45
RSI50.94
Earnings DateAug 14, 2025

About CALT

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company offers Chinese herbal medicines, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, female beauty, and health care. It also provides functio... [Read more]

Sector Healthcare
Founded 1969
Employees 501
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1707
Full Company Profile

Financial Performance

In 2024, Grape King Bio's revenue was 11.16 billion, an increase of 4.93% compared to the previous year's 10.64 billion. Earnings were 1.45 billion, a decrease of -0.30%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.